Please email us at Sales@AmericanPharmaWholesale.com with our item No, NDC#,UPC#or best is product link. We are located in Oceanside, California. Search over 100,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name.
Menu

REPATHA 420 MG SYS 3.5 ML by Amgen

REPATHA 420 MG SYS 3.5 ML by AmgenAmgen IncThis Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).REPATHA 420 MG SYS 3.5 ML by AmgenREPATHA 420 MG SYS 3.5 ML by AmgenNDC 55513-0760-02 UPC/GTIN No.3-55513-76002-7 Mfg.Part No.76002

REPATHA 420 MG SYS 3.5 ML by Amgen

$585.00$530.00

NDC No.72511-0770-01 72511-770-01 UPC/GTIN No.3-72511-77001-8 MPN 77001 Only Physician,Pharmacy or Licensed Facility can order this Rx Item No.Rx823492 823492 REPATHA 420 MG SYS 3.5 ML by Amgen evolocumab SUBCUT WEAR INJCT 420 MG/3.5 Item No.3435057 NDC No.72511077001 7251177001 UPC No.372511-770018 372511-770018 Other Name Repatha, EVOLOCUMAB SUB-Q SYRIN Therapeutic Code 240624 Therapeutic Class Pcsk9 Inhibitors Item Class Non Controlled Rx. Case Qnty: 28 Therapeutic Code 240624 Pcsk9 Inh

Have a question?

Clinical Information
Gen. Code and Des.
76353 evolocumab SUBCUT WEAR INJCT 420 MG/3.5
Strength
420 mg/3.5 mL
Dose Form
WEARABLE INJECTOR
Product Category
RX Pharmaceuticals
Fine Line Class
850085008510 All Rx Products
DEA Class
NC
OMP Family

AHFS Class
24062400 PCSK9 INHIBITORS
Active Ingredients
16368 evolocumab
Inactive Ingredients
3245 adhesive
9865 polysorbate 80 9005656


REPATHA- evolocumab injection, solution
REPATHA- evolocumab
Amgen Inc

1 INDICATIONS AND USAGE

1.1 Primary Hyperlipidemia
REPATHA® is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (CVD), who require additional lowering of low density lipoprotein cholesterol (LDL-C).

1.2 Homozygous Familial Hypercholesterolemia


REPATHA is indicated as an adjunct to diet and other LDL-lowering therapies (e.g., statins, ezetimibe, LDL apheresis) for the treatment of patients with homozygous familial hypercholesterolemia (HoFH) who require additional lowering of LDL-C.

1.3 Limitations of Use
The effect of REPATHA on cardiovascular morbidity and mortality has not been determined.

2 DOSAGE AND ADMINIST R ATION

2.1 Recommended Dosage
The recommended subcutaneous dosage of REPATHA in patients with HeFH or patients with primary hyperlipidemia with established clinical atherosclerotic CVD is either 140 mg every 2 weeks OR 420 mg once monthly. When switching dosage regimens, administer the first dose of the new regimen on the next scheduled date of the prior regimen.

The recommended subcutaneous dosage of REPATHA in patients with HoFH is 420 mg once monthly. In patients with HoFH, measure LDL-C levels 4 to 8 weeks after starting REPATHA, since response to therapy will depend on the degree of LDL-receptor function.

If an every 2 week or once monthly dose is missed, instruct the patient to:

Administer REPATHA as soon as possible if there are more than 7 days until the next scheduled dose, or,
Omit the missed dose and administer the next dose according to the original schedule.

REPATHA 420 MG SYS 3.5 ML by Amgen
REPATHA 420 MG SYS 3.5 ML
REPATHA 420 MG SYS 3.5 ML by Amgen

Amgen Inc
REPATHA 420 MG SYS 3.5 ML
Amgen Inc

This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).
EVOLOCUMAB SUB-Q PEN INJC
This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).

REPATHA 420 MG SYS 3.5 ML by Amgen
Amgen Inc
REPATHA 420 MG SYS 3.5 ML by Amgen

REPATHA 420 MG SYS 3.5 ML by Amgen
REPATHA 420 MG SYS 3.5 ML
REPATHA 420 MG SYS 3.5 ML by Amgen

NDC 55513-0760-02 UPC/GTIN No.3-55513-76002-7 Mfg.Part No.76002
Repatha 140mg/ml Inj 2 by Amgen
NDC 55513-0760-02 UPC/GTIN No.3-55513-76002-7 Mfg.Part No.76002